{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:06:28Z","timestamp":1789596388365,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Sexual dysfunction, including problems with vaginal dryness, dyspareunia, decreased libido, and difficulty with orgasm, is a common complaint among female breast cancer survivors. Despite the prevalence of female sexual dysfunction, there is a lack of Food and Drug Administration (FDA)-approved treatment options for hypoactive sexual desire disorder (HSDD) in women. Testosterone therapy may be one option.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This is a case series describing the experience of breast cancer patients who used testosterone to treat sexual dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We report on three patients with a history of breast cancer who chose to continue testosterone therapy for improved sexual function despite conflicting reports of efficacy and lack of safety data on testosterone use in breast cancer patients. The patients described here expressed understanding of the risks and adamantly wished to continue testosterone therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>All patients received a comprehensive sexual medicine evaluation including complete gynecological and psychosexual evaluations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The improved sexual functioning is a quality-of-life parameter for these patients, and the unknown testosterone safety profile is an individually accepted level of risk. As studies emerge reporting beneficial effects of testosterone on libido and sexual function, the use of testosterone-containing therapies can be expected to increase among postmenopausal women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Further studies are needed to investigate the long-term effects of testosterone use in patients with breast cancer or at increased risk for developing breast cancer to definitively address the safety issues.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2007.00577.x","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T21:06:31Z","timestamp":1185915991000},"page":"1769-1774","source":"Crossref","is-referenced-by-count":17,"title":["A Case Series of Androgen Use in Breast Cancer Survivors with Sexual Dysfunction"],"prefix":"10.1093","volume":"4","author":[{"given":"Michael L.","family":"Krychman","sequence":"first","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center\u2014Surgery\/Gynecology , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J.","family":"Stelling","sequence":"additional","affiliation":[{"name":"Albany Medical College\u2014Medical Student , Albany, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Carter","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center\u2014Surgery\/Gynecology , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Hudis","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center\u2014Breast Cancer Medicine Service , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2024032600531979300_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1008298615272","article-title":"Sexual dysfunction in treated breast cancer patients","volume":"8","author":"Barni","year":"1997","journal-title":"Ann Oncol"},{"key":"2024032600531979300_bb0015","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.ejca.2005.05.017","article-title":"Quality of life among long-term breast cancer survivors: A systemic review","volume":"41","author":"Mols","year":"2005","journal-title":"Eur J Cancer"},{"key":"2024032600531979300_bb0020","first-page":"1591","article-title":"Testosterone treatments: Why, when, and how?","volume":"73","author":"Margo","year":"2006","journal-title":"Am Fam Physician"},{"key":"2024032600531979300_bb0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial","volume":"105","author":"Buster","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2024032600531979300_bb0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifrin","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600531979300_bb0035","first-page":"1012","article-title":"A two-year, double-blind comparison of estrogen\u2013androgen and conjugated estrogens in surgically menopausal women: Effects on bone mineral density, symptoms, and lipid profiles","volume":"44","author":"Barrett-Connor","year":"1999","journal-title":"J Reprod Med"},{"key":"2024032600531979300_bb0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00002820-199608000-00007","article-title":"Sexual functioning in women with breast cancer after treatment with adjuvant therapy","volume":"19","author":"Young-McCaughan","year":"1996","journal-title":"Cancer Nurs"},{"key":"2024032600531979300_bb0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.GME.0000142887.31811.97","article-title":"The effects of postmenopausal hormone therapies on female sexual functioning: A review of double-blind, randomized controlled trials","volume":"11","author":"Alexander","year":"2004","journal-title":"Menopause"},{"key":"2024032600531979300_bb0050","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.gme.0000243567.32828.99","article-title":"Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study","volume":"13","author":"Shifren","year":"2006","journal-title":"Menopause"},{"key":"2024032600531979300_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/17455057.2.3.459","article-title":"Testosterone and libido in surgically and naturally menopausal women","volume":"2","author":"Alexander","year":"2006","journal-title":"Women's Health"},{"issue":"3","key":"2024032600531979300_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1743-6109.2007.00449.x","article-title":"Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women","volume":"4","author":"Kinsberg","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600531979300_bb0065","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial","volume":"165","author":"Braunstein","year":"2005","journal-title":"Arch Intern Med"},{"key":"2024032600531979300_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.gme.0000177709.65944.b0","article-title":"The role of testosterone therapy in postmenopausal women: Position statement of the North American Menopause Society","volume":"12","author":"North American Menopause Society","year":"2005","journal-title":"Menopause"},{"key":"2024032600531979300_bb0075"},{"key":"2024032600531979300_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fertnstert.2005.01.119","article-title":"The relative effects of hormones and relationship factors on sexual function of women through the natural menopause transition","volume":"84","author":"Dennerstein","year":"2005","journal-title":"Fertil Steril"},{"key":"2024032600531979300_bb0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1075-122X.2005.00131.x","article-title":"Study of sexual functioning determinants in breast cancer survivors","volume":"11","author":"Speer","year":"2005","journal-title":"Breast J"},{"key":"2024032600531979300_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"key":"2024032600531979300_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042192-200103000-00006","article-title":"Factors related to sexual function in postmenopausal women with a history of breast cancer","volume":"8","author":"Greendale","year":"2001","journal-title":"Menopause"},{"key":"2024032600531979300_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.GME.0000119983.48235.D3","article-title":"Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy","volume":"11","author":"Dimitrakakis","year":"2004","journal-title":"Menopause"},{"key":"2024032600531979300_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.gme.0000232033.92411.51","article-title":"Testosterone inhibits estrogen\/progestogen-induced breast cell proliferation in postmenopausal women","volume":"14","author":"Hofling","year":"2007","journal-title":"Menopause"},{"key":"2024032600531979300_bb0110","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/ijc.22203","article-title":"Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women","volume":"119","author":"Adly","year":"2006","journal-title":"Int J Cancer"},{"key":"2024032600531979300_bb0115","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/archinte.166.14.1483","article-title":"Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women","volume":"166","author":"Tamimi","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024032600531979300_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.20582","article-title":"Serum testosterone levels and breast cancer recurrence","volume":"113","author":"Berrino","year":"2005","journal-title":"Int J Cancer"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515317094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515317094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/6\/1769\/47812985\/jsm_4_6_1769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/6\/1769\/47812985\/jsm_4_6_1769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:42:57Z","timestamp":1711417377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/4\/6\/1769\/6890502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00577.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,11]]},"published":{"date-parts":[[2007,11,1]]}}}